Per a Sep 18 article published on Duke University website, NuVasive, Inc. (NASDAQ:NUVA) has reportedly closed another acquisition. This time, it is a start-up company called Vertera Spine, created through research at both Duke University and the Georgia Institute of Technology. However, financial terms of the deal have not been disclosed.
NuVasive, which has just extended its global headquarter in San Diego, currently focuses on applying procedurally-integrated solutions for minimally disruptive spine surgeries. The latest development remains part of this strategy, having steadily strengthened NuVasive’s global position.
The company aims to market and distribute Vetera Spine’s FDA-approved COHERE Cervical and COALESCETM Lumbar Interbody fusion devices in the United States.
This acquisition has also lent the company a three-dimensional porous interbody technology across both polyetheretherketone (PEEK) and titanium materials. Notably, the company has introduced a few new features in its Modulus XLIF, built on a fully-porous titanium implant and created in three-dimensional manufacturing process as well as designed to match the porosity and stiffness of bone.
It is encouraging to note that the company’s U.S. Spinal Hardware business, comprising implants and fixation products like MAGEC-EOS spinal bracing and lengthening system plus the PRECICE limb lengthening system, registered 3% growth in the recently reported quarter. NuVasive is therefore leaving no stone unturned to gain traction in this fast-growing spine market.
In this regard, the company has been steadily focusing on product development. It claims to possess an active corporate development pipeline that includes a number of strategic investments, acquisitions and partnership opportunities. Notably, during the first quarter of 2017, the company launched the first two interbody devices, MLX and TLX, used in lumbar fusion procedures.
Per a report from Becker’s Spine Review, the global minimally-invasive spine surgery market is expected to witness a CAGR of 7.6% between 2017 and 2021. Also, per a report by Technavio, the global spinal implants market is expected to witness a CAGR of roughly 6% in the 2016-2020 period.
Thus, given the current market potential, we believe the company is on the right track to gain traction. We also believe that an ageing population, unhealthy lifestyle, rising awareness and expenditure in healthcare will continue to drive growth in this minimally-invasive spine surgery market.
However, this market is also dominated by many well-established players like Stryker Corporation (NYSE:SYK) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH) and RTI Surgical (NASDAQ:RTIX) among others. Notably, Stryker provides a range of products with ES2 Spinal systems, MANTIS implants, LITe Decompression tubes and many more under minimally-invasive spine surgical solutions portfolio. Zimmer Biomet’s collection of thoracolumbar products forms a comprehensive portfolio for minimally-invasive spine surgery.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
RTI Surgical, Inc. (RTIX): Free Stock Analysis Report
Stryker Corporation (SYK): Free Stock Analysis Report
NuVasive, Inc. (NUVA): Free Stock Analysis Report
Zimmer Biomet Holdings, Inc. (ZBH): Free Stock Analysis Report
Original post